Roche's Chugai part­ners with Swiss ADC biotech Araris

Chugai, a Japan­ese phar­ma owned by Roche, is part­ner­ing with a small Swiss biotech to work on next-gen­er­a­tion an­ti­body-drug con­ju­gates that de­liv­er mul­ti­ple cy­to­tox­ic mol­e­cules …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER